Actavis to buy Allergan for $66 billion By: L.A. Biz via Business Journals November 17, 2014 at 14:59 PM EST Irish drugmaker Actavis plc has agreed to buy Botox maker Allergan Inc. in a cash and stock deal worth $66 billion... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.
